Wellington Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,280
Closed -$2.01M 2204
2022
Q3
$2.01M Buy
13,280
+2,296
+21% +$347K ﹤0.01% 1526
2022
Q2
$1.6M Sell
10,984
-124,300
-92% -$18.1M ﹤0.01% 1584
2022
Q1
$16M Buy
135,284
+33,437
+33% +$3.96M ﹤0.01% 1072
2021
Q4
$14M Buy
101,847
+815
+0.8% +$112K ﹤0.01% 1165
2021
Q3
$14M Sell
101,032
-175,810
-64% -$24.4M ﹤0.01% 1174
2021
Q2
$26.9M Sell
276,842
-1,538,512
-85% -$149M ﹤0.01% 1019
2021
Q1
$124M Buy
1,815,354
+229,102
+14% +$15.7M 0.02% 544
2020
Q4
$136M Sell
1,586,252
-754,357
-32% -$64.7M 0.03% 507
2020
Q3
$152M Buy
2,340,609
+257,228
+12% +$16.7M 0.03% 436
2020
Q2
$152M Sell
2,083,381
-1,034,992
-33% -$75.7M 0.03% 419
2020
Q1
$106M Buy
3,118,373
+1,578,708
+103% +$53.7M 0.03% 445
2019
Q4
$83.8M Buy
1,539,665
+147,145
+11% +$8.01M 0.02% 611
2019
Q3
$58.1M Buy
1,392,520
+420,799
+43% +$17.6M 0.01% 688
2019
Q2
$42.6M Sell
971,721
-413,045
-30% -$18.1M 0.01% 802
2019
Q1
$71.3M Sell
1,384,766
-191,658
-12% -$9.86M 0.02% 641
2018
Q4
$58.3M Buy
1,576,424
+379,374
+32% +$14M 0.01% 675
2018
Q3
$44.9M Buy
1,197,050
+113,327
+10% +$4.26M 0.01% 836
2018
Q2
$42.8M Buy
1,083,723
+2,659
+0.2% +$105K 0.01% 842
2018
Q1
$27.8M Buy
1,081,064
+562,633
+109% +$14.5M 0.01% 961
2017
Q4
$14M Sell
518,431
-307,014
-37% -$8.28M ﹤0.01% 1169
2017
Q3
$30.9M Buy
825,445
+469,338
+132% +$17.5M 0.01% 912
2017
Q2
$8.9M Buy
+356,107
New +$8.9M ﹤0.01% 1249